Ever since the first glaucoma surgery in 1856, the goal has been to decrease intraocular
pressure (IOP), the only modifiable risk and prognostic factor for glaucoma. Over the years …

Glaucoma is the leading cause of irreversible blindness with over 70 million people affected
worldwide. The surgical management of glaucoma aims to lower intraocular pressure by …

Purpose Determine how procedural treatments for glaucoma have changed between 1994–
2012. Design Retrospective, observational analysis. Participants Medicare Part B …

Purpose To compare the clinical outcomes of the EX-PRESS glaucoma filtration device
placed under a partial-thickness scleral flap with trabeculectomy. Design Randomized …

Comparison of trabeculectomy and Ex-PRESS implantation in fellow eyes of the same patient:
a prospective, randomised study | Eye Skip to main content Thank you for visiting nature.com …

PURPOSE:: To investigate bleb morphologic features and postoperative outcomes after Ex-
PRESS drainage device (Alcon Laboratories) implantation versus trabeculectomy. DESIGN …

Purpose: To compare the efficacy and safety of the Ex-PRESS glaucoma shunt with
standard trabeculectomy. Patients and Methods: Consenting patients with medically …

Purpose: The purpose of this study was to assess the safety and efficacy of the PSM for the
treatment of open angle glaucoma with 0.2 mg/mL mitomycin C, either alone or in …

Purpose To report on the long-term outcomes and risk factors for failure with the EX-PRESS
shunt implanted under a scleral flap. Settings Eye Department, University of Ancona …

Glaucoma filtration surgery is performed to reduce intraocular pressure (IOP) in patients for
whom maximal tolerable pharmacologic IOP-lowering therapy and/or laser surgery fail to …